Development and Characterization of Biphenylsulfonamides as Novel Inhibitors of Bone Resorption-Reference-Cited by-同舟云学术

Development and Characterization of Biphenylsulfonamides as Novel Inhibitors of Bone Resorption

Published:2006-11-11 Issue:25 Volume:49 Page:7487-7492
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Greig Iain R.¹,Idris Aymen I.¹,Ralston Stuart H.¹,van't Hof Rob J.¹

Affiliation:

1. School of Medicine, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, U.K., and Rheumatic Diseases Unit, University of Edinburgh, Molecular Medicine Centre, Edinburgh EH4 2XU, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm051236m

Reference29 articles.

1. Bone Resorption by Osteoclasts

2. Pathogenesis of bone fragility in women and men

3. Paget disease of bone

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Green Sulfonation;Industrial Arene Chemistry;2023-03-10

2. Sustainable access to sulfonic acids from halides and thiourea dioxide with air;Green Chemistry;2020

3. Disperse red 15 (DR15) impedes biofilm formation of uropathogenic Escherichia coli;Microbial Pathogenesis;2020-01

4. OP0293 A FIRST-IN-CLASS METABOLIC REPROGRAMMING AGENT, MBS2320, SELECTIVELY MODULATES IMMUNE CELL FUNCTION AND IMPROVES OSTEOID FORMATION AND BONE PROTECTION VERSUS ETANERCEPT IN THE MOUSE COLLAGEN-INDUCED ARTHRITIS MODEL;Oral Presentations;2019-06

5. SAT0045 A NOVEL SMALL MOLECULE, MBS2133, MODULATES OSTEOCLAST PRE-CURSOR METABOLISM TO INHIBIT OSTEOCLAST DIFFERENTIATION: AN ALTERNATIVE THERAPY FOR OSTEOLYTIC PATHOLOGY IN RA;SATURDAY, 15 JUNE 2019;2019-06